Joint Polish Investment Fund
VC Fund
Warsaw, Poland
Joint Polish Investment Fund is a VC fund in Warsaw focused on Health Care and Medical Device. Joint Polish Investment Fund is Poland-based group has reportedly become the country's first institutional venture capital fund. JPIF invests in early and mid stage Life Science companies in Central and Eastern Europe with an investment holding period of 3-5 years. In addition the JPIF team also look at Polish companies which have licensed,partnered, or acquired technologies from abroad. JPIF's aim is to create a high return investment portfolio that leverages the Polish life science capabilities.JPIF consists of a team of people with broad experience in the life-science sector. Scientists and medical doctors with industrial experience work hand in glove with colleagues who have a thorough training in economics and business affairs. Everybody is driven by true interest in the life science field and new technologies, which will greatly contribute to people’s health disease management and quality of life.Entrepreneurs backed by JPIF have access to the knowledge and advice of each member of the JPIF team and to the associated global scientific and commercial network. Together JPIF and entrepreneurs are therefore in the position to accelerate preclinical, clinical or commercial development and a successful market entry into the most important healthcare markets: Europe, the U.S., and Asia.The management team of JPIF has a long track record in sourcing, structuring and selling businesses ranging from seed stage to more mature, revenue generating companies.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 91%
- Fund size:
- $42M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Joint Polish Investment Fund invests in
Stages Joint Polish Investment Fund invests in
Countries Joint Polish Investment Fund invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $2.3M–$2.3M
Investment Focus
Industry
- Health Care 5 (45%)
- Medical Device 3 (27%)
- Apps 2 (18%)
- Medical 2 (18%)
- Manufacturing 2 (18%)
Stage
- Venture - Series Unknown 4 (36%)
- Series A 3 (27%)
- Seed 2 (18%)
Country
- Poland 5 (45%)
- United States 3 (27%)
- Israel 1 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Anna Aranowska-Bablok
General Partner
|
General Partner | Total investments: 1 | Find email | |
Axel Polack
General Partner
|
General Partner | Total investments: 12 | Find email | |
Anna Rusek
Financial Director
|
Financial Director | Total investments: 0 | Find email | |
Marek Orlowski
General Partner
|
General Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| We’re a team of scientists, designers and entrepreneurs working on digital solutions to empower people to sleep and dream better. After 3 years of research and experiments in a sleep lab as well as cooperation with sleep medicine experts, neuropsychologists, audiovisual researchers, we've found a way to improve sleep quality with activesleep stimulation. To make it accessible to the wide public we've developed the Nightly app - the world’s first app that actively stimulates you during sleep to make your sleep more efficient resulting in happier and healthier you. Nightly helps you fall asleep easily, reduces bad dreams & the number of awakenings during the night and also helps you get up by waking you up in the lightest sleep stage. Find out more at www.nightlyapp.co | $2.3M / Series A / Sep 15, 2017 | ||
| Nightly helps you enjoy healthy sleep. It actively works to keep your night restful in three ways: it helps you easily fall asleep, limit bad dreams and reduce the likelihood of nighttime awakenings. This innovative, scientifically-developed technology is a combination of two factors: audio-visual stimuli and advanced AI algorithms.Nightlymonitors your sleep live, recognizes critical moments during your night and reacts with soothing sounds to help you minimize the possibility of a wakeup. It stimulates your sleep to help you keep your rest uninterrupted. | $2.3M / Series A / Sep 15, 2017 | ||
| Smartmedics is a privately owned digital healthcare company with operations in Warsaw, Poland. It consists of experts in R&D, design, engineering, data science, software and healthcare professionals with years of relevant clinical experience. | Venture - Series Unknown / Aug 02, 2017 | ||
| Fixnip offers nipple reconstruction implants that include a nitinol frame designed to provide a mechanical structure that is covered by silicone and has no contact with the breast tissue. They are designed to allow for anchoring of the implant to adjacent tissue and breast reconstruction surgery for women. | Venture - Series Unknown / Aug 02, 2017 | ||
| PHase2 Micro Technologies is a technology development company that offers MEMS-enabled pH sensor technology platforms.PHase2 Micro Technologies’ AccuMET™ pH sensing platforms include single measurement chips (SMCs) designed for discrete single measurements as well as multiple measurement chips (MMCs). They also include continuous self-calibratingchips (CSCs), which are designed to use in continuous monitoring applications.PHase2 Micro Technologies is based in Boston, Massachusetts. | Venture - Series Unknown / Mar 03, 2016 | ||
| ScaleThings is a privately-owned company which develops and manufactures proprietary tactile-sensing weighing technologies embedded in a diverse range of consumer retail products for home, wearables, health and baby care. | Venture - Series Unknown / Mar 01, 2016 | ||
| MySpiroo by Healthup - Ultraportable spirometer The MySpiroo is a spirometer, a device which helps to control asthma, reduces the number of exacerbations and protects from life-threatening attacks. | $1.1M / Seed / Feb 03, 2016 | ||
| Sound Object Technologies is develops technology for obtaining and processing information from sound signals for application in medical devices. | Seed / Dec 10, 2015 | ||
| MANTA Instruments Inc. (MANTA) is commercializing scientific instruments that use breakthrough technology to characterize nanoparticles much more effectively than existing products. Existing instruments for characterizing nanoparticles are unable to: i) adequately measure concentration of nanoparticles, ii) measure samples with mixednanoparticle sizes, and iii) reliably measure changes in nanoparticle size over time. | Series A / Dec 10, 2015 | ||
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Joint Polish Investment Fund invest in?
Joint Polish Investment Fund invests primarily in Health Care, Medical Device and Apps startups, most often at Venture - Series Unknown and Series A stage. Most of the 11 investments tracked by Shizune back companies in Poland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Joint Polish Investment Fund invest in?
Joint Polish Investment Fund typically joins rounds of $2.3M–$2.3M at Series A. These are whole funding-round sizes, not Joint Polish Investment Fund's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Joint Polish Investment Fund took part in.
How do I contact Joint Polish Investment Fund?
Public channels for Joint Polish Investment Fund include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Joint Polish Investment Fund?
The team at Joint Polish Investment Fund includes Anna Aranowska-Bablok (General Partner), Axel Polack (General Partner) and Anna Rusek (Financial Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
